Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Block

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Seminars in Nephrology|May 29, 2016
Ferric Citrate in Patients With Chronic Kidney DiseaseGeoffrey A Block
Kidney International. Supplement|October 9, 2003
The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal diseaseGeoffrey A Block
Current Opinion in Nephrology and Hypertension|April 27, 2011
Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortalityGeoffrey A Block
Hemodialysis International. International Symposium on Home Hemodialysis|June 30, 2006
Phosphate binders: new products and challengesAntonio Bellasi, Laura Kooienga, Geoffrey A Block
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2007
Factors associated with mortality in patients new to haemodialysisDavid M Spiegel, Paolo Raggi, Gerard Smits, et al.
American Journal of Nephrology|January 25, 2017
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease PatientsFrancesco Locatelli, Steven Fishbane, Geoffrey A Block, et al.
Current Medical Research and Opinion|March 20, 2015
A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patientsGregory Bell, Saling Huang, Kevin J Martin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2006
Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patientsPaul Muntner, Emiliana Ferramosca, Antonio Bellasi, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 29, 2012
Integration of clinical and imaging data to predict death in hemodialysis patientsAntonio Bellasi, Geoffrey A Block, Emiliana Ferramosca, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2019
Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 TrialGeoffrey A Block, David P Rosenbaum, Andrew Yan, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Seminars in Nephrology|May 29, 2016
Ferric Citrate in Patients With Chronic Kidney DiseaseGeoffrey A Block
Kidney International. Supplement|October 9, 2003
The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal diseaseGeoffrey A Block
Current Opinion in Nephrology and Hypertension|April 27, 2011
Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortalityGeoffrey A Block
Hemodialysis International. International Symposium on Home Hemodialysis|June 30, 2006
Phosphate binders: new products and challengesAntonio Bellasi, Laura Kooienga, Geoffrey A Block
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2007
Factors associated with mortality in patients new to haemodialysisDavid M Spiegel, Paolo Raggi, Gerard Smits, et al.
American Journal of Nephrology|January 25, 2017
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease PatientsFrancesco Locatelli, Steven Fishbane, Geoffrey A Block, et al.
Current Medical Research and Opinion|March 20, 2015
A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patientsGregory Bell, Saling Huang, Kevin J Martin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2006
Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patientsPaul Muntner, Emiliana Ferramosca, Antonio Bellasi, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 29, 2012
Integration of clinical and imaging data to predict death in hemodialysis patientsAntonio Bellasi, Geoffrey A Block, Emiliana Ferramosca, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2019
Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 TrialGeoffrey A Block, David P Rosenbaum, Andrew Yan, et al.
Pageof 12